536565
NOVELIX
Start SIP
Invest Now
Start SIP in NOVELIX
Performance
- Low
- ₹60
- High
- ₹62
- 52 Week Low
- ₹24
- 52 Week High
- ₹70
- Open Price₹61
- Previous Close₹60
- Volume2,417
- 50 DMA₹56.99
- 100 DMA₹51.36
- 200 DMA₹42.07
Investment Returns
- Over 1 Month + 10.31%
- Over 3 Month + 48.75%
- Over 6 Month + 34.37%
- Over 1 Year + 146.38%
Smart Investing Starts Here Start SIP with Novelix Pharmaceuticals for Steady Growth!
Novelix Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 99
- PEG Ratio
- 0
- Market Cap Cr
- 96
- P/B Ratio
- 3.5
- Average True Range
- 3.43
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.89
- RSI
- 50.38
- MFI
- 58.95
Novelix Pharmaceuticals Financials
Novelix Pharmaceuticals Technicals
EMA & SMA
Current Price
₹59.50
0
(0%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹59.80
- 50 Day
- ₹56.99
- 100 Day
- ₹51.36
- 200 Day
- ₹42.07
Resistance and Support
59.4
- R3 64.41
- R2 62.71
- R1 61.10
- S1 57.79
- S2 56.09
- S3 54.48
Novelix Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-14 | Quarterly Results & A.G.M. | |
| 2025-06-24 | Others | Inter alia, to consider and approve 1. The conversion of Warrants into Equity Shares of the Company. |
| 2025-05-27 | Audited Results | |
| 2025-04-12 | Others | Inter-alia, to consider 1. Convening of an EGM for appointment of Non-Executive Independent Director of the Company. 2. To appoint a scrutinizer for the upcoming EGM. 3. Other business matters. |
Novelix Pharmaceuticals F&O
About Novelix Pharmaceuticals
- NSE Symbol
- NOVELIX
- BSE Symbol
- 536565
- ISIN
- INE314I01036
Similar Stocks to Novelix Pharmaceuticals
Novelix Pharmaceuticals FAQs
Novelix Pharmaceuticals share price is ₹59 As on 09 January, 2026 | 13:45
The Market Cap of Novelix Pharmaceuticals is ₹96 Cr As on 09 January, 2026 | 13:45
The P/E ratio of Novelix Pharmaceuticals is 99 As on 09 January, 2026 | 13:45
The PB ratio of Novelix Pharmaceuticals is 3.5 As on 09 January, 2026 | 13:45
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.